Not Yet Recruiting
A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae
NCT07647029
- Conditions
- Blood Platelet Disorders, Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT), Breast Diseases, +9 more
- Locations
-
Not specified